Search
GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
---|---|---|---|---|---|
ebi-a-GCST011039 | 2020 | Parkinson's disease progression (composite) | NA | 2,755 | 591,724 |
ebi-a-GCST90093341 | 2020 | Binding antibody response to interferon beta therapy in multiple sclerosis (antibody levels; all treatment preparations) | NA | 2,745 | 7,781,212 |
met-a-719 | 2014 | X-14189--leucylalanine | NA | 2,745 | 2,545,768 |
ebi-a-GCST90093336 | 2020 | Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; all treatment preparations) | NA | 2,744 | 7,772,374 |
ebi-a-GCST90093331 | 2020 | Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; all treatment preparations) | NA | 2,744 | 7,625,406 |
Data overview
The GWAS summary datasets are currently organised into the following 18 batches: